Posts Tagged ‘
IMCL ’
Oct 7th, 2008 |
By William Patalon III |
Category: Financial News, International Investing
S&P Slashes RBS Rating; Dendreon’s Big Boost; Eli Lilly Comes Out Ahead on ImClone; AgFeed’s Hungry For Its Own Shares; Bank of America Surprises with Loss; Paulson Taps Another Goldman Exec.
Tags: , BAC, Bmy, DNDN, FEED, GS, Hank Paulson, IMCL, Lly, Rbs, tech stocks, US Banking, William Patalon III
Posted in Financial News, International Investing |
No Comments »
Oct 2nd, 2008 |
By William Patalon III |
Category: Financial News, Politics & Economics
Eli Outbids Bristol; Carmax Crashes; IBM Could Miss Estimates; Micron’s Loss; Cereal’s Sugar High; Canada Drives Toyota
Tags: Bmy, Ford Motor Co., Gm, IBM, IMCL, Kellogg Co.’s, KFT, KMX, Lly, MU, TM, U.S. credit crisis, US Jobless Rate, US stocks, William Patalon III
Posted in Financial News, Politics & Economics |
No Comments »
Sep 24th, 2008 |
By William Patalon III |
Category: Financial News, International Investing
Home Prices Still Dropping; Chrysler Chases GM; Oil Slides Back; Lennar Loss Beats Estimates; Kullman to Helm DuPont; ImClone Plays Hard to Get; France and Britain Nuclear Match?
Tags: Bmy, Chrysler LLC, Crude Oil Prices, DD, EICFF, Gm, IMCL, LEN, US stocks, William Patalon III
Posted in Financial News, International Investing |
No Comments »
Sep 17th, 2008 |
By William Patalon III |
Category: Financial News, International Investing
Oil Continues Slide; FDA Blocks Ranbaxy, Best Buy Profit Declines; Bristol-Myers Bid Uncertain; Pandit’s Reassuring Memo; GM Showcases the Volt; Adobe Beats the Street; Constellation Plunges on Debt Worries
Tags: ADBE, BBY, Bmy, CEG, Citigroup Inc, Crude Oil Prices, Gm, IMCL, RBXLY, US Banking, US stocks, William Patalon III
Posted in Financial News, International Investing |
No Comments »
Aug 7th, 2008 |
By Contrarian Profits |
Category: Featured, Financial News
There has been a lot of strong recommendations around biotech lately on Contrarian Profits.
Phase 1 Investor editor Rob Fannon recently wrote that biotech was one of the few market sectors to show positive returns as many other stocks were getting hammered. He sees great values in the sector.
There’s a good reason for this strength. A struggling economy won’t hurt biotech and medical as much as, say, an automaker, retailer, or restaurant chain… And biotech is one of the few industries showing solid sales growth.
Tags: BIIB, Bmy, CELG, DNA, GENZ, GILD, IMCL, investing in biotech, Jim Nelson, Rob Fannon, Steve Sjuggerud, XBI
Posted in Featured, Financial News |
No Comments »
Aug 7th, 2008 |
By Jim Nelson |
Category: Featured, Financial News
As investors plowed into financial and housing stocks in the last few years, they forgot about the pharmaceutical industry, says Jim Nelson in Penny Sleuth.
But now that the party is over, biotech stocks are coming back in a big way. According to mutual-fund research firm Lipper, two biotech funds were amongst the top five best-performing vehicles in July – a dramatic reversal from June when commodities funds were leading the charge.
Big Pharma is buying up promising biotech companies in an effort to boost profit margins. This creates great opportunities for investors, and it’ only just the beginning…
Tags: Bmy, DNA, IMCL, investing in biotech, Jim Nelson, Roche Holdings, US stocks
Posted in Featured, Financial News |
No Comments »
Aug 1st, 2008 |
By William Patalon III |
Category: Financial News, International Investing
Bristol Myers Moves for ImClone; Kodak Earnings Fade; Diana Shipping Doubles Earnings; Crude Stumbles Again; Google to Start VC Fund; Primetime Ad Drama; MasterCard Slumps on Less Spending; S&P Says U.S. Car Companies are “Junk”
- Bristol-Myers Squibb Co. (BMY) yesterday (Thursday) offered $4.5 billion in cash for biotechnology company ImClone Systems Inc. (IMCL), the Associated Press reported. ImClone’s board has yet to comment on the proposal, which offers its stockholders $60 per share, a 30% premium to its Wednesday closing price of $46.44. Bristol-Myers already owns about 17% of ImClone.
- Eastman Kodak Co. (EK) said yesterday (Thursday) that second-quarter profit fell, as traditional film-based revenue slumped 14% to $847 million. Sales climbed 1% from $2.47 billion to $2.49 billion, and revenue from digital businesses rose 10%…
Tags: Bmy, CBS, Crude Oil Prices, CSCO, DSX, EK, Ford Motor Co., Gm, GOOG, IMCL, INTC, M&A, MSFT, William Patalon III
Posted in Financial News, International Investing |
No Comments »
May 17th, 2008 |
By Rob Fannon |
Category: Stock Market Investing
Last May, shares of Regeneron Pharmaceuticals (REGN), a billion-dollar biotech, slid 35% in just 30 days. The company had no press releases, no earnings reports, nothing.
Tags: ASCO, Biotech Stocks, CELG, DNA, EXEL, IMCL, IMGN, Ivory Tower, MEDX, New Drugs, ONXX, Regeneron Pharmaceuticals, US stocks
Posted in Stock Market Investing |
No Comments »
May 15th, 2008 |
By Mike Caggeso |
Category: Stock Market Investing
Carl Icahn is adding to his reputation as a boardroom bully. In a letter to Yahoo Inc. (YHOO) Chairman Roy Bostock, the billionaire investor threatened to seek control of the board and resuscitate takeover talks with Microsoft Corp. (MSFT).
Tags: BBI, Blockbuster, Carl Icahn, CC, Circuit City Stores, Federal Trade Commission, IMCL, Imclone Systems, Jerry Yang, Microsoft, MOT, Motorola, MSFT, Steve Ballmer, Yahoo, YHOO
Posted in Stock Market Investing |
No Comments »